Skip to main content

 8HHL | pdb_00008hhl

Cryo-EM structure of the Cas12m2-crRNA-target DNA full R-loop complex


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.87 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 8HHL

This is version 1.3 of the entry. See complete history. 

Literature

Mechanistic and evolutionary insights into a type V-M CRISPR-Cas effector enzyme.

Omura, S.N., Nakagawa, R., Sudfeld, C., Villegas Warren, R., Wu, W.Y., Hirano, H., Laffeber, C., Kusakizako, T., Kise, Y., Lebbink, J.H.G., Itoh, Y., van der Oost, J., Nureki, O.

(2023) Nat Struct Mol Biol 30: 1172-1182

  • DOI: https://doi.org/10.1038/s41594-023-01042-3
  • Primary Citation Related Structures: 
    8HHL, 8HHM, 8HIO

  • PubMed Abstract: 

    RNA-guided type V CRISPR-Cas12 effectors provide adaptive immunity against mobile genetic elements (MGEs) in bacteria and archaea. Among diverse Cas12 enzymes, the recently identified Cas12m2 (CRISPR-Cas type V-M) is highly compact and has a unique RuvC active site. Although the non-canonical RuvC triad does not permit dsDNA cleavage, Cas12m2 still protects against invading MGEs through transcriptional silencing by strong DNA binding. However, the molecular mechanism of RNA-guided genome inactivation by Cas12m2 remains unknown. Here we report cryo-electron microscopy structures of two states of Cas12m2-CRISPR RNA (crRNA)-target DNA ternary complexes and the Cas12m2-crRNA binary complex, revealing structural dynamics during crRNA-target DNA heteroduplex formation. The structures indicate that the non-target DNA strand is tightly bound to a unique arginine-rich cluster in the recognition (REC) domains and the non-canonical active site in the RuvC domain, ensuring strong DNA-binding affinity of Cas12m2. Furthermore, a structural comparison of Cas12m2 with TnpB, a putative ancestor of Cas12 enzymes, suggests that the interaction of the characteristic coiled-coil REC2 insertion with the protospacer-adjacent motif-distal region of the heteroduplex is crucial for Cas12m2 to engage in adaptive immunity. Collectively, our findings improve mechanistic understanding of diverse type V CRISPR-Cas effectors and provide insights into the evolution of TnpB to Cas12 enzymes.


  • Organizational Affiliation: 
    • Department of Biological Sciences, Graduate School of Science, the University of Tokyo, Tokyo, Japan.

Macromolecule Content 

  • Total Structure Weight: 107.03 kDa 
  • Atom Count: 6,971 
  • Modeled Residue Count: 703 
  • Deposited Residue Count: 726 
  • Unique protein chains: 1
  • Unique nucleic acid chains: 3

Macromolecules


Find similar proteins by:|  3D Structure
Entity ID: 4
MoleculeChains  Sequence LengthOrganismDetailsImage
Cas12m2D [auth A]598Mycolicibacterium mucogenicumMutation(s): 0 
UniProt
Find proteins for P0DXB1 (Mycolicibacterium mucogenicum)
Explore P0DXB1 
Go to UniProtKB:  P0DXB1
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DXB1
Sequence Annotations
Expand
Reference Sequence
Find similar nucleic acids by:  (by identity cutoff) 
Entity ID: 1
MoleculeChains LengthOrganismImage
crRNA (56-MER)A [auth B]56Mycolicibacterium mucogenicum
Sequence Annotations
Expand
Reference Sequence
Find similar nucleic acids by:  (by identity cutoff) 
Entity ID: 2
MoleculeChains LengthOrganismImage
TS (36-MER)B [auth C]36Mycolicibacterium mucogenicum
Sequence Annotations
Expand
Reference Sequence
Find similar nucleic acids by:  (by identity cutoff) 
Entity ID: 3
MoleculeChains LengthOrganismImage
NTS (36-MER)C [auth D]36Mycolicibacterium mucogenicum
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.87 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Japan Agency for Medical Research and Development (AMED)Japan--

Revision History  (Full details and data files)

  • Version 1.0: 2023-04-12
    Type: Initial release
  • Version 1.1: 2023-07-19
    Changes: Database references
  • Version 1.2: 2023-08-09
    Changes: Database references
  • Version 1.3: 2023-08-30
    Changes: Data collection, Database references